BioSpace News Archive

Pfizer, in partnership with leading patient advocacy organizations and healthcare professionals, provides women and men living with metastatic breast cancer with a new tool to have informed conversations with their doctors about their treatment options

InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that Moshe Mizrahy , Chairman and Chief Executive Officer, Dr. Michael Kreindel , co-founder and Chief Technology Officer, Yair Malca , Chief Financial Officer, Dr. Spero Theodorou , Chief Medical Officer, and Shakil Lakhan

A New Drug Application for the Review of Tenapanor to Control Serum Phosphorus in Adult Patients with Chronic Kidney Disease on Dialysis has Been Submitted to the FDA

Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, and Asuragen, a molecular diagnostics company delivering easy-to-use products for complex testing in ge

Masimo SedLine® Brain Function Monitoring with PSi Processed EEG Helped Identify the Oversedations

Goldfinch Bio, a clinical stage biotechnology company focused on discovering and developing precision medicines for the treatment of kidney diseases, today announced that company management will participate in two upcoming investor conferences in August: William Blair Biotech Focus Conference 2020 on Thursday, August 6, 2020 Anthony Johnson, M.D., President and Chief Executive Officer, will participate in a p

Aileron Therapeutics (NASDAQ:ALRN) today announced that Manuel Aivado, M.D., Ph.D., President and Chief Executive Officer, will participate in two upcoming investor conferences this month. Thursday, August 6, 2020 Event: William Blair Biotech Focus Conference 2020 Time: 12:00 pm ET *Fireside chat Thursday, August 13, 2020 Event: Canaccord Genuity 40 th Annual Growth Conference Time: 4:30 pm ET *Company overview and business

NTT Research, Inc., a division of NTT, announced that it has opened an office in Munich, in support of a joint research agreement it entered with the Technical University of Munich in November 2019.

ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that the Company’s second quarter 2020 financial results will be released after market close on Monday, August 10, 2020. ChemoCentryx executive management will host a conference call and webcast beginning at 5:00 p.m. Eastern Time on August 10, 2020 to discuss these results and to answer questions. To participate by telephone, please dial (877) 303-8028 (Domestic) or (760) 536-5167 (I

Evofem Biosciences, Inc. (NASDAQ: EVFM) is proud to announce that CEO Saundra Pelletier was named to the PharmaVOICE 100 Most Inspiring People, an annual list of the 100 most innovative, influential and inspirational people in the life-sciences industry.